Allergy to nickel: first results on patients administered with an oral hyposensitization therapy.
Nickel sulphate allergy is the most common contact allergy. In fact, nickel sulphate is an ubiquitous element, contained in various objects and food; it occurs in igneous rocks, as a free metal and together with iron, but it is also a component of living organism, mainly vegetables. We carried out a clinical trial of oral hyposensitization therapy with low doses of nickel in a group of 67 patients affected by systemic allergy to this sensitizer element. We obtained good results on consequent tolerance to nickel in treated patients.
Tammaro
A
A
De Marco
G
G
Persechino
S
S
Narcisi
A
A
Camplone
G
G
D000284:Administration, Oral; D000485:Allergens / Q000008:administration & dosage*; D017449:Dermatitis, Allergic Contact / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D003888:Desensitization, Immunologic; D004334:Drug Administration Schedule; D006801:Humans; D007108:Immune Tolerance; D007428:Intradermal Tests; D009532:Nickel / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
D000485:Allergens; C029938:nickel sulfate; D009532:Nickel